Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Terminated 4Completed 4Unknown 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Other 4

Conditions

Opioid-Induced Constipation 4

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × naloxegol × Clear all
NCT01395524 2017-02-23

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
302 enrolled 13 charts
Other

Opioid-Induced Constipation

NCT01323790 2015-06-02

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
700 enrolled 25 charts
Other

Opioid-Induced Constipation

NCT01309841 2015-06-01

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
652 enrolled 25 charts
Other

Opioid-Induced Constipation

NCT01336205 2014-10-20

Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
844 enrolled 10 charts
Other

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡